下一代肿瘤不可知靶点即将出现
Next-generation tumor-agnostic targets on the horizon.
肿瘤不可知药物开发将肿瘤学重新聚焦于共享的分子依赖性而非组织来源,从而能够针对跨肿瘤的罕见可操作驱动因素进行高效开发。
英文原题:Correlation of tumor-infiltrating lymphocyte spatial distribution patterns with HER2 expression status and prognostic significance in gastric adenocarcinoma: a retrospective study based on digital pathology.
Correlation of tumor-infiltrating lymphocyte spatial distribution patterns with HER2 expression status and prognostic significance in gastric adenocarcinoma: a retrospective study based on digital pathology.
HER2阳性胃腺癌表现出“边缘限制性”免疫表型,E/C比值升高。在常规H&E切片上进行TILs数字化评估简便且有望用于临床转化。
TIL(肿瘤浸润淋巴细胞)(TILs)的空间分布对实体瘤具有预后价值,但其与胃腺癌HER2状态的关系仍缺乏充分表征。
在H&E染色切片上使用QuPath评估肿瘤中心(CT)和浸润边缘(IM)的TIL密度,并计算边缘/中心比值(E/C比值 = IM-TILs/CT-TILs)。E/C比值的最佳截断值通过最大化log-rank统计量确定。生存分析采用Kaplan-Meier法和Cox回归进行。
HER2阳性组(n = 35)的CT-TILs显著低于HER2阴性组(n = 165)(11.92% vs. 20.98%,P < 0.001),E/C比值显著高于HER2阴性组(2.11 vs. 1.25,P < 0.001)。采用最佳截断值1.57时,高E/C比值与整个队列中显著更差的总生存期(OS)相关(中位14.64 vs. 42.87个月;log-rank P < 0.001)。校正临床病理因素后的多因素Cox回归显示,E/C比值作为连续变量具有独立预后意义(HR = 1.398,P < 0.001),且观察到HER2状态与E/C比值之间存在显著交互作用(HR = 1.844,P = 0.001)。以E/C > 1.57进行二分法分组可提供显著的预后分层,该效应受HER2状态影响;然而,由于HER2阳性亚组样本量较小,这些发现需要在更大的独立队列中验证。
BACKGROUND: The spatial distribution of tumor-infiltrating lymphocytes (TILs) has prognostic value in solid tumors, but its relationship with HER2 status in gastric adenocarcinoma remains poorly characterized. METHODS: TIL densities in the tumor center (CT) and at the invasive margin (IM) were assessed on H&E-stained slides using QuPath, and the edge/center ratio (E/C ratio = IM-TILs/CT-TILs) was calculated. The optimal cut-off for E/C ratio was determined by maximizing the log-rank statistic. Survival analyses were performed using Kaplan-Meier and Cox regression. RESULTS: The HER2-positive group (n = 35) exhibited significantly lower CT-TILs (11.92% vs. 20.98%, P < 0.001) and a higher E/C ratio (2.11 vs. 1.25, P < 0.001) than the HER2-negative group (n = 165). Using an optimal cut-off of 1.57, high E/C ratio was associated with significantly worse overall survival (OS) in the whole cohort (median 14.64 vs. 42.87 months; log-rank P < 0.001). Multivariate Cox regression, adjusting for clinicopathological factors, revealed that the E/C ratio as a continuous variable was independently prognostic (HR = 1.398, P < 0.001), and a significant interaction between HER2 status and E/C ratio was observed (HR = 1.844, P = 0.001). Dichotomization at E/C > 1.57 provides significant prognostic stratification, an effect that is modified by HER2 status; however, due to the small HER2-positive subgroup, these findings require validation in larger independent cohorts. CONCLUSIONS: HER2-positive gastric adenocarcinoma exhibits an "edge-limiting" immune phenotype with elevated E/C ratio. Digital assessment of TILs on routine H&E sections is simple and promising for clinical translation.
MEMBER ACCOUNT
登录成功会直接打开下一页。